Treatment of Chlamydia in Pregnancy
Treat pregnant women with chlamydial infection using azithromycin 1 g orally as a single dose OR amoxicillin 500 mg orally three times daily for 7 days as first-line therapy.
Recommended Treatment Regimens
The most recent CDC guidelines (2006) elevated azithromycin to a recommended first-line agent alongside amoxicillin, representing an important shift from earlier guidelines 1. This change was based on clinical experience and studies demonstrating azithromycin's safety and effectiveness in pregnancy.
First-Line Options:
Alternative Regimens (if first-line agents not tolerated):
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin base 250 mg orally four times daily for 14 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days 1
Key Clinical Considerations
Contraindicated medications: Doxycycline, ofloxacin, and levofloxacin are absolutely contraindicated in pregnancy 1. Erythromycin estolate is also contraindicated due to drug-related hepatotoxicity 1.
Why azithromycin is preferred: Research demonstrates azithromycin achieves 97% microbiological cure rates compared to only 64% for erythromycin 2. Additionally, azithromycin causes significantly fewer gastrointestinal side effects than erythromycin, improving patient compliance 3, 2. The single-dose regimen eliminates adherence concerns entirely.
Amoxicillin efficacy: High-quality evidence shows amoxicillin is equally effective as erythromycin for microbiological cure (no significant difference, RR 0.97) but is substantially better tolerated with fewer side effects (RR 0.31) 3.
Mandatory Follow-Up Testing
Perform repeat testing (preferably by NAAT) 3 weeks after completion of therapy in ALL pregnant women 1. This is critical because:
- None of the pregnancy-safe regimens achieve 100% efficacy
- Erythromycin's frequent side effects may compromise compliance
- Persistent infection poses serious risks to both mother and neonate, including ophthalmia neonatorum, neonatal pneumonia, and postpartum endometritis
Partner Management
Treat all sexual partners who had contact with the patient during the 60 days preceding symptom onset or diagnosis. Treat the most recent partner even if contact occurred >60 days prior 1.
Instruct the patient to abstain from sexual intercourse until:
- 7 days after completing a single-dose regimen (azithromycin), OR
- After completing the full 7-day course of multi-dose regimens 1
Evidence Quality and Evolution
The progression from 1998-2002 guidelines (which listed azithromycin only as an alternative with insufficient safety data) 4, 5 to 2006 guidelines (which promoted azithromycin to first-line based on accumulated clinical experience) 1 reflects growing confidence in its safety profile. A 2017 Cochrane review confirmed that azithromycin and clindamycin result in fewer side effects than erythromycin, though all agents achieve similar microbiological cure rates 3.
Common Pitfalls to Avoid
- Do not use doxycycline - this is the standard non-pregnancy treatment but is teratogenic
- Do not skip the 3-week test of cure - this is not optional in pregnancy due to neonatal transmission risks
- Do not use erythromycin estolate - only erythromycin base or ethylsuccinate formulations are safe
- Do not assume partner treatment occurred - verify and document partner notification and treatment